药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfamethazine
Methscopolamine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Methscopolamine.
Sulfamethazine
Thonzylamine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Thonzylamine.
Sulfamethazine
Butylscopolamine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Butylscopolamine.
Sulfamethazine
Imidafenacin
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Imidafenacin.
Sulfamethazine
Dosulepin
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Dosulepin.
Sulfamethazine
Trimebutine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Trimebutine.
Sulfamethazine
Benactyzine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Benactyzine.
Sulfamethazine
Dexetimide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Dexetimide.
Sulfamethazine
Aclidinium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Aclidinium.
Sulfamethazine
Dimetindene
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Dimetindene.
Sulfamethazine
Hexocyclium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Hexocyclium.
Sulfamethazine
Pizotifen
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Pizotifen.
Sulfamethazine
Mepenzolate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Mepenzolate.
Sulfamethazine
Rapacuronium
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Rapacuronium.
Sulfamethazine
Isopropamide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Isopropamide.
Sulfamethazine
Solifenacin
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Solifenacin.
Sulfamerazine
Sulfate ion
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Sulfate ion.
Sulfamerazine
Sodium cation
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Sodium cation.
Sulfamerazine
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Dehydrocholic acid is combined with Sodium phosphate, dibasic.
Sulfamerazine
Frangula purshiana bark
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Frangula purshiana bark.